U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07469709) titled 'A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks' on March 03.
Brief Summary: The PRO-ACTIVE study aims to develop a clinical-translational program in the field of cancer prevention in all its phases (primary, secondary, and tertiary) to intervene before the clinical and radiological manifestation of the disease. It starts with risk prediction and leads to early diagnosis of the disease or recurrence in the subclinical phase.
The PRO-ACTIVE study includes the following activities:
* WP1: Integrated DNA-RNA approach for the identification of hereditary markers o...